Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc., South San Francisco, CA – FDA Inspections
Inspection records and compliance data for Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. in South San Francisco, California. 3 FDA inspections on record, last inspected February 06, 2015.
This profile covers Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. based in South San Francisco, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 2
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected January 20, 2012. Last inspected February 6, 2015.
Most cited issue areas
- Ensuring compliance with plan and protocol1 inspection
- General responsibilities of sponsors1 inspection
- Late submission of 15-day report1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 6, 2015 | NAI | Human Drugs · Drug Quality Assurance | 914497 |
| May 17, 2013 | VAI | Human Drugs · Bioresearch Monitoring | 833837 |
| January 20, 2012 | VAI | Human Drugs · Bioresearch Monitoring | 765467 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.
FEI Number
3009255166
Address
Onyx Pharmaceuticals, Inc., 249 E Grand Ave, South San Francisco, California 94080, United States
Country
United States
ID: 99535d65-fff9-419e-bf57-d11ae158e2e4